Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Potential of telomerase inhibitors for chemoprevention emerges from recent research

Jan. 25, 2001

Scotia's Foscan receives negative opinion from EMEA

Jan. 24, 2001

Medarex and B. Twelve to develop human antibody therapeutics for cancer

Jan. 24, 2001

Novel oral cancer treatments to be codeveloped by Celltech and Johnson & Johnson

Jan. 23, 2001

Oral formulation of Fludara now available in U.K.

Jan. 23, 2001

Second-generation retroviral BRCA1 vector for ovarian cancer has improved preclinical profile

Jan. 23, 2001

British Biotech provides update on clinical development of marimastat

Jan. 23, 2001

Celltech Group claims new series of squaric acid derivatives

Jan. 22, 2001

MMP inhibitors from Pfizer reportedly useful for inflammatory disorders and cancer

Jan. 22, 2001

Two new clinical trials commence with Genasense for leukemia

Jan. 22, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...